TY - JOUR
KW - narcotics
KW - Substance Use Disorders -- Drug Therapy
KW - Buprenorphine -- Administration and Dosage
KW - Buprenorphine -- Urine
KW - Creatinine -- Urine
KW - Urinalysis
KW - Human
KW - Retrospective Design
KW - Record Review
KW - Descriptive Statistics
KW - Analysis of Variance
KW - Buprenorphine -- Therapeutic Use
KW - Administration, Sublingual
KW - Drug Monitoring
KW - Substance Abuse Detection
AU - Hiroko Furo
AU - Diane G. Schwartz
AU - Ross W. Sullivan
AU - Peter L. Elkin
A1 - 
AD - Department of Biomedical Informatics, State University of New York (SUNY) at Buffalo, Buffalo, NY, USA; Department of Psychiatry and Behavioral Sciences, The University of Texas Health at San Antonio, San Antonio, TX, USA; Department of Emergency Medicine, State University of New York (SUNY) Upstate Medical University, Syracuse, NY, USA
BT - Substance Abuse: Research & Treatment
C5 - Education & Workforce; Healthcare Disparities; Opioids & Substance Use
CY - Thousand Oaks, California
DO - 10.1177/11782218211061749
JF - Substance Abuse: Research & Treatment
LA - English
M1 - Journal Article
PB - Sage Publications Inc
PP - Thousand Oaks, California
PY - 2021
SN - 1178-2218
SP - 1
EP - 9
EP - 
T1 - Buprenorphine Dosage and Urine Quantitative Buprenorphine, Norbuprenorphine, and Creatinine Levels in an Office-Based Opioid Treatment Program
T2 - Substance Abuse: Research & Treatment
TI - Buprenorphine Dosage and Urine Quantitative Buprenorphine, Norbuprenorphine, and Creatinine Levels in an Office-Based Opioid Treatment Program
U1 - Education & Workforce; Healthcare Disparities; Opioids & Substance Use
U3 - 10.1177/11782218211061749
UR - https://search.ebscohost.com/login.aspx?direct=true&db=cin20&AN=154321675&site=ehost-live
VO - 1178-2218
Y1 - 2021
Y2 - 1
ER -